Back

Financial Controller

Financial Controller

Pharmaceutical / Biotechnology / Chemical
  • Permanent full time
  • Reference : INT-030486
  • Share:

Details

  • Region Zurich Unterland / Limmattal
  • Type of contract Permanent full time
  • Sector of activity Pharmaceutical / Biotechnology / Chemical

Introduction

For our client a leading supplier of medical and surgical instrument sterilization, disinfection, cleaning products and services, located in Zug, we are looking for an individual as

Financial Controller

The earliest start date is as soon as possible.

Description of the mission

  • Reviewing the monthly financial performance and deliver accurate and compliant reporting to the executive management
  • Providing financial insights and identifying profitability potential to the business
  • Creating ad-hoc analyzes, proposing and implementing improvements to the reporting process and data analytics
  • Leading or supporting cross-functional projects to optimize global processes
  • Leading and developing a junior controller
  • You are responsible for strategic planning, monthly forecasting and budget
  • You are a sparring partner for our Business and HQ activities in Zug (ZG) as well as our Operations in Sulgen (TG)


Required profile

  • Masters' degree in economics, business administration, or equivalent experience
  • 5+ years of experience in controlling in an industrial environment, ideally as industrial and business controller
  • Experience in project cost management and standard costing
  • High IT and technology affinity with experience in financial systems (SAP FI-CO, Cognos)
  • Accounting knowledge of SWISS GAAP FER
  • Excel expert
  • Proactive, problem-solver, hands-on, entrepreneurial, resilient
  • Fluent in English, knowledge of German is a plus


Application process:

Interested? You can find more information here: Infopackage. Please apply via the "Bewerben" button below and answer all questions, otherwise we will be unable to process your application.

Information

  • Reference INT-030486
  • Published on 10 juin 2022
  • ConsultantMarijke van Engelenburg